Company profile

Simcere Pharmaceutical

2096 · HKEX

Public Market Listing

2096HKEX

HKEX primary exchange listing

Live quotes, historical charts, and market capitalization for Simcere Pharmaceutical are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(3 total)
3Total Assets
0Approved
2Phase 3 / Filed
1Phase 1–2 / Early
4Diseases
Quick filter:
Showing 3 of 3 assets
Target & Modality
Endostar
Phase 3
VEGFR2 (KDR/Flk-1) on vascular endothelial cellsSmall molecule
Non-Small Cell Lung Cancer
Rademikibart
Phase 3
IL-4R-alphaMonoclonal antibody
Atopic DermatitisChronic Obstructive Pulmonary Disease
SIM0500
Phase 1
GPRC5D x BCMA x CD3Multispecific antibody
Multiple Myeloma

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.